Abstract
Michael reaction acceptors (MRAs) are a class of active compounds. There is a great prospect to screen STAT3 inhibitors from Eupatorium lindleyanum, furthermore, to discover lead compounds for anti-triple-negative breast cancer (TNBC). In this study, glutathione (GSH) was employed, and a UPLC-MS screening method was developed to discover MRAs. We screened MRAs which can inhibit STAT3 using a STAT3-dependent reporter system. Six sesquiterpene lactones, including a new compound Eupalinolide O (1), together with five known compounds, Eupalinolide I (2), Eupalinolide K (3), Eupalinolide H (4), Eupalinolide J (5) and Eupalinolide G (6) were isolated. Eupalinolide J was identified as MRA that decreased luciferase activity of STAT3. Preliminary activity assessment showed that Eupalinolide J could inhibit the viability of TNBC cell lines. We demonstrated that Eupalinolide J, which is a natural typical MRA, has a notable inhibition of STAT3 activity and a potential cytotoxic activity against TNBC cell lines.
References
Oct 1, 1995·Journal of Ethnopharmacology·A CáceresG Carrillo
Sep 25, 2004·Journal of Natural Products·Jun HuoJian-Min Yue
Mar 1, 2005·Oncogene·Jiazhi SunSaïd M Sebti
Jun 1, 2005·Journal of Natural Products·Ya-Ching ShenAshraf Taha Khalil
Nov 23, 2006·Chemistry & Biology·Jochen SchustThorsten Berg
Jun 1, 1994·Planta medica·D Youssef, A W Frahm
Jul 7, 2007·Journal of Asian Natural Products Research·N-Y YangL-J Tian
Aug 27, 2009·Cancer Research·Ying WangQiang Yu
Jul 2, 2014·British Journal of Cancer·X ZhangS M Sebti
Dec 2, 2014·Cancer Letters·Jaemoo ChunYeong Shik Kim
Jun 25, 2015·Frontiers in Oncology·Valeria Poli, Annalisa Camporeale
Oct 26, 2016·Oncology Reports·Bo YangHuajun Zhao
Nov 1, 2017·Natural Product Research·Xixi LiuXuelei Xin
Dec 23, 2017·Natural Product Research·Weiming XuYuguo Zheng
Apr 14, 2018·Chinese Medicine·Zhongzhen ZhaoEric Brand
Citations
Jul 20, 2018·Chemistry, an Asian Journal·Abdul SadeerPak-Hing Leung
Aug 26, 2020·Cell Biology International·Behrooz JohariHamed Rezaeejam
Mar 1, 2020·Cell Communication and Signaling : CCS·Jia-Hui MaXia Li
May 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Jiang-Jiang QinWei-Dong Zhang
Oct 15, 2019·Frontiers in Pharmacology·Chenghua LouHuajun Zhao
Jan 15, 2020·The Journal of Toxicological Sciences·Zeqi WuChenghua Lou
Apr 2, 2019·Natural Product Research·Yong HouJunxing Dong
Aug 19, 2020·Journal of Ethnopharmacology·Zimei YangXiufei Gao
Feb 2, 2021·Frontiers in Pharmacology·Xueyi WangChenghua Lou
Mar 3, 2021·Journal of Medicinal Chemistry·Minru LiaoBo Liu
Nov 21, 2020·Neoplasia : an International Journal for Oncology Research·Zhihui ZhuHuajun Zhao
May 18, 2021·Chemistry & Biodiversity·Han ChenXiaoling Lu
Jul 17, 2021·Acta Pharmacologica Sinica·Yan ZhongXiao-Lei Zhang
Jun 30, 2021·Journal of Separation Science·Lu HuangYu-Ping Tang
Oct 10, 2021·Chemical Biology & Drug Design·Sahil ButalaTabassum Khan